Plasmonic Sensing Assay for Long-Term Monitoring (PSALM) of Neurotransmitters in Urine

Wei-Hsin Chen, Wenting Wang, Qianqi Lin, David Benjamin Grys, Marika Niihori, Junyang Huang, Shu Hu, Bart de Nijs, Oren A. Scherman, Jeremy J. Baumberg*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
17 Downloads (Pure)

Abstract

A liquid-based surface-enhanced Raman spectroscopy assay termed PSALM is developed for the selective sensing of neurotransmitters (NTs) with a limit of detection below the physiological range of NT concentrations in urine. This assay is formed by quick and simple nanoparticle (NP) "mix-and-measure"protocols, in which FeIII bridges NTs and gold NPs inside the sensing hotspots. Detection limits of NTs from PreNP PSALM are significantly lower than those of PostNP PSALM, when urine is pretreated by affinity separation. Optimized PSALM enables the long-term monitoring of NT variation in urine in conventional settings for the first time, allowing the development of NTs as predictive or correlative biomarkers for clinical diagnosis.

Original languageEnglish
Pages (from-to)161–171
JournalACS Nanoscience Au
Volume3
Issue number2
Early online date24 Dec 2022
DOIs
Publication statusPublished - 2023
Externally publishedYes

Keywords

  • dopamine
  • neurotransmitters
  • self-assembly
  • sensing
  • SERS
  • urine

Fingerprint

Dive into the research topics of 'Plasmonic Sensing Assay for Long-Term Monitoring (PSALM) of Neurotransmitters in Urine'. Together they form a unique fingerprint.

Cite this